p.Ala541Thr variant of MEN1 gene: A non deleterious polymorphism or a pathogenic mutation?
Cécile Nozières(Inserm), Alain Calender(Centre Léon Bérard), Marine Guillaud-Bataille, Catherine Cardot-Bauters(Centre Hospitalier Universitaire de Lille), Pierre Goudet(Inserm), Martine Cordier–Bussat(Université Claude Bernard Lyon 1), S. Dupasquier(Hôpital Edouard Herriot), Lionel Groussin(Université Paris Cité), Rosa Vargas‐Poussou(Hôpital Européen Georges-Pompidou), Françoise Borson‐Chazot(Hospices Civils de Lyon), Marie‐Françoise Odou, Alexandre Buffet(Inserm), Chang-Xian Zhang(Centre Léon Bérard), Sophie Giraud(Hospices Civils de Lyon), Sophie Christin-Maître(Inserm), Arnaud Murat(Centre National de la Recherche Scientifique), Valérie Hervieu(Hospices Civils de Lyon), Marie‐Odile Joly(Lyon 1 Université), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Philippe Ruszniewski(Inserm), Delphine Vezzosi(Université Toulouse III - Paul Sabatier)
Cited by 11
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772